全文获取类型
收费全文 | 4567篇 |
免费 | 176篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 224篇 |
妇产科学 | 60篇 |
基础医学 | 238篇 |
口腔科学 | 20篇 |
临床医学 | 738篇 |
内科学 | 511篇 |
皮肤病学 | 24篇 |
神经病学 | 275篇 |
特种医学 | 124篇 |
外科学 | 559篇 |
综合类 | 773篇 |
预防医学 | 271篇 |
眼科学 | 12篇 |
药学 | 819篇 |
5篇 | |
中国医学 | 63篇 |
肿瘤学 | 72篇 |
出版年
2023年 | 47篇 |
2022年 | 154篇 |
2021年 | 153篇 |
2020年 | 146篇 |
2019年 | 119篇 |
2018年 | 125篇 |
2017年 | 124篇 |
2016年 | 134篇 |
2015年 | 138篇 |
2014年 | 328篇 |
2013年 | 358篇 |
2012年 | 274篇 |
2011年 | 320篇 |
2010年 | 273篇 |
2009年 | 236篇 |
2008年 | 203篇 |
2007年 | 196篇 |
2006年 | 194篇 |
2005年 | 168篇 |
2004年 | 131篇 |
2003年 | 109篇 |
2002年 | 66篇 |
2001年 | 76篇 |
2000年 | 65篇 |
1999年 | 60篇 |
1998年 | 58篇 |
1997年 | 41篇 |
1996年 | 42篇 |
1995年 | 48篇 |
1994年 | 53篇 |
1993年 | 32篇 |
1992年 | 31篇 |
1991年 | 24篇 |
1990年 | 24篇 |
1989年 | 17篇 |
1988年 | 18篇 |
1987年 | 21篇 |
1986年 | 17篇 |
1985年 | 23篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 15篇 |
1981年 | 14篇 |
1980年 | 12篇 |
1979年 | 10篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1972年 | 5篇 |
1971年 | 6篇 |
排序方式: 共有4802条查询结果,搜索用时 0 毫秒
101.
102.
103.
104.
Summary Sixteen adult patients of mean age 48 years with chronic ITP were studied for platelet response to high-dose (0.4 g/kg body weight per day for five consecutive days) intravenous polyvalent intact IgG in the absence of any concurrent treatment. The platelet count returned to normal values in nine patients, a partial response (rise in the platelet count between 50 and 150 ×109/l) was observed in three cases. One patient refractory to any other treatment went into a sustained remission. In the other responsive patients the response was only transient. Among seven splenectomised patients only three responded to IgG infusions versus nine in the non-splenectomised group. The length of ITP history appeared as a more critical factor for the response to IgG than previous splenectomy. 相似文献
105.
该文报道1例静脉注射免疫球蛋白(intravenous immunogloblin,IVIG)无应答不完全性川崎病患儿。1岁女性患儿,表现为发热、皮疹、指端脱皮、冠状动脉扩张,给予第一剂IVIG治疗结束36 h后仍发热,再次给予第二剂IVIG治疗后体温恢复正常,出院1个月后随访冠状动脉内径恢复正常。该文总结了IVIG无应答不完全性川崎病的诊治经验,以期减少冠状动脉损害的发生。 相似文献
106.
目的 探讨川崎病(Kawasaki disease,KD)患儿丙种球蛋白(intravenous immunoglobulin,IVIG)治疗前发热时间与IVIG耐药的关系。方法 回顾性收集2018年1月至2020年12月收治KD患儿317例的病例资料,根据IVIG治疗前发热时间分为短热程组(发热时间≤4 d,n=92)和长热程组(发热时间>4 d,n=225),根据是否发生IVIG耐药将每组再分为耐药组和非耐药组。分析比较不同热程耐药组及非耐药组的基线资料及实验室结果,并采用多因素logistic回归分析IVIG耐药的影响因素。结果 短热程组中IVIG耐药19例(20.7%),并发冠状动脉瘤5例(5.4%);长热程组中IVIG耐药22例(9.8%),并发冠状动脉瘤19例(8.4%);短热程组IVIG耐药率明显高于长热程组(P<0.05),而冠状动脉瘤发生率在两组间差异无统计学意义(P>0.05)。短热程组中,耐药患儿治疗前血钠水平低于非耐药患儿,而降钙素原、C反应蛋白及N末端B型利钠肽原水平则明显高于非耐药患儿(P<0.05)。长热程组中,耐药患儿治疗前血钠及肌酸激酶水平低于非耐药患儿(P<0.05)。多因素logistic回归分析显示,血钠水平降低与长热程组KD患儿IVIG耐药有关(P<0.05)。结论 KD患儿IVIG耐药因IVIG治疗前发热时间不同而异。在治疗前发热时间>4 d的KD患儿中,血钠降低与IVIG耐药具有相关性。 相似文献
107.
Lee JH Choi SJ Lee JH Kim SE Park CJ Chi HS Lee MS Lee JS Kim WK Lee KH 《Annals of hematology》2005,84(5):321-330
We investigated the occurrence of hepatic veno-occlusive disease (VOD) after allogeneic bone marrow transplantation (BMT) in 241 adults conditioned with busulfan + cyclophosphamide at a single institute and retrospectively compared 186 patients who received oral busulfan (O-Bu group) with 55 patients who received intravenous busulfan (I-Bu group). Various hemostatic parameters were determined at baseline and on days 0, 7, 14, and 21. Hepatic VOD occurred in 41.7% of the O-Bu group and in 18.5% of the I-Bu group. Multivariate analysis revealed that the I-Bu group had significantly decreased risk of VOD compared to the O-Bu group [p=0.006, odds ratio: (OR) 0.345]. Eleven patients in the O-Bu group and none of the I-Bu group developed severe VOD. A repeated measures analysis of variance (ANOVA) with a between-subjects factor revealed significant differences in post-transplant levels of antithrombin III, tissue plasminogen activator (tPA), plasminogen activator inhibitor 1 (PAI-1), and D-dimer according to the occurrence of VOD. The level of antithrombin III was significantly lower, whereas the level of D-dimer was significantly higher, in the O-Bu group than in the I-Bu group. These findings show that, in adults conditioned with busulfan + cyclophosphamide, intravenous busulfan was associated with significantly decreased incidence of VOD and fewer hemostatic derangements after allogeneic BMT compared to oral busulfan. 相似文献
108.
Summary Data from single injection studies on 23 normal subjects led to development of an intravenous primed — constant infusion test. The plasma glucose response to this test was determined in 48 normal and 24 diabetic subjects. Variation in plasma glucose concentration at equilibrium was minimal in normal and marked in diabetic subjects — assessed by the difference between maximum and minimum glucose concentration over the final 25 min of a 50 min infusion. This parameter was used successfully in predicting the course of 16 pregnant women with clinical suspicion of prediabetes unresolved by oral glucose tolerance tests.Submitted as part fulfillment of the requirements for Doctor of Medicine, Monash University, Melbourne, 1967. 相似文献
109.
Walter F. Haupt Felix Rosenow Christian van der Ven Helmut Borberg Gunter Pawlik 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》1997,1(1):55-57
Abstract: Plasma exchange and administration of intravenous immunoglobulin (IgG) are established treatments for Guillain-Barré syndrome (GBS). Elimination of postulated pathogenetic factors by plasma exchange or selective adsorption treatment using affinity-type adsorption columns and subsequent immunomodulation by intravenous IgG may provide a more effective treatment. Forty-five patients with acute GBS were prospectively examined using a clinical score. We treated 11 patients by plasma exchange, 13 patients by selective adsorption using a tryptophan-linked polyvinyl alcohol gel adsorbent, and 21 patients by selective adsorption followed by intravenous IgG. The patients treated sequentially by selective adsorption and intravenous IgG improved significantly better than the patients who received plasma treatment only. The results suggest that sequential treatment of GBS may be superior to plasma treatment alone. The higher cost of combined treatment may be offset by lower overall expenditure. 相似文献
110.
Intravenous immunoglobulin (IVIg) is used to treat a number of immune-deficiencies and autoimmune diseases. It has been shown that IVIg contains anti-idiotypic antibodies, which explains its immunomodulatory action.In murine models, recent investigations have demonstrated that IVIg can prevent and reduce the affliction by systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS) and scleroderma. Relevant disease-specific fractions of IVIg were able to reproduce and even enhance the therapeutic effect in a murine model.IVIg treatment before tumor resection in rodents inoculated with melanoma and sarcoma cells dramatically improved the cure rate (50%) in comparison to the control group (0%).In patients affected by SLE, several clinical manifestations responded to IVIg treatment including serositis, hematological manifestations, treatment-resistant nephritis and central nervous system involvement. Similarly, in women with recurrent fetal loss due to APS, IVIg was able to diminish the abortion rate. Vasculitides such as Churg–Strauss' and Wegener's and skin fibrosis in patients affected by scleroderma improved after IVIg treatment. In agreement with in vitro investigations, prolonged survival has been noted in cancer patients treated with IVIg.We suggest that in the presence of a steroid and immunosuppressive-resistant autoimmune disease, IVIg is a rational and safe choice. 相似文献